Search tips
Search criteria

Results 1-4 (4)

Clipboard (0)

Select a Filter Below

more »
Year of Publication
author:("yazdani, J")
1.  Validity of a Self-administered Version of the Brief Index of Lupus Damage in a Predominantly African American Systemic Lupus Erythematosus Cohort 
Arthritis care & research  2014;66(6):888-896.
To assess the reliability, criterion and construct validity of the self-administered Brief Index of Lupus Damage (SA-BILD), a patient-reported measure of organ damage in systemic lupus erythematosus (SLE).
The validity of the SA-BILD was assessed using data from the Georgians Organized Against Lupus (GOAL) survey. GOAL is longitudinal cohort of SLE patients predominantly derived from the Georgia Lupus Registry, a population-based registry established in Atlanta, Georgia, United States (US). Seven hundred eleven participants with documented SLE completed the SA-BILD. To test reliability, the SA-BILD was re-administered to 32 patients. Criterion validity was examined in 150 respondents for whom the SLICC/ACR Damage Index (SDI) was also completed. Construct validity was assessed among 711 GOAL participants dividing the SA-BILD scores into quartiles and examining the association with demographics, health status and health care utilization.
The test-retest correlation score was 0.93 (p<0.0001). The item-by-item agreement with the SDI was over 80% for most SA-BILD items. The Spearman rank correlation for SDI and SA-BILD was moderately high (r=0.59, p<0.0001). SA-BILD scores showed significant associations in the expected directions with age, disease duration, disease activity, overall health, comorbidity index, and physician visits.
The SA-BILD is reliable and has very good or good criterion validity compared to the SDI when tested in a predominantly African American cohort of US SLE patients. Associations of SA-BILD scores with sociodemographics and health status are consistent with previous studies. These findings support the use of SA-BILD as a valid measure of patient-reported damage in SLE.
PMCID: PMC4025986  PMID: 24249662
Systemic Lupus Erythematosus; disease outcomes; patient-reported damage; instrument validation
4.  Association of Sweet's Syndrome and Systemic Lupus Erythematosus 
Case Reports in Rheumatology  2011;2011:242681.
Sweet's syndrome is an acute febrile neutrophilic dermatosis which usually presents as an idiopathic disorder but can also be drug induced, associated with hematopoetic malignancies and myelodysplastic disorders, and more, infrequently, observed in autoimmune disorders. Sweet's syndrome has been reported in three cases of neonatal lupus, three cases of hydralazine-induced lupus in adults, and in nine pediatric and adult systemic lupus erythematosus (SLE) patients. We describe three additional adult cases of Sweet's associated with SLE and provide a focused review on nondrug-induced, nonneonatal SLE and Sweet's. In two of three new cases, as in the majority of prior cases, the skin rash of Sweet's paralleled underlying SLE disease activity. The pathogenesis of Sweet's remains elusive, but evidence suggests that cytokine dysregulation may be central to the clinical and pathological changes in this condition, as well as in SLE. Further research is needed to define the exact relationship between the two conditions.
PMCID: PMC3420725  PMID: 22937442

Results 1-4 (4)